Evidence map›Paper›PMID 34349769›Full record

ArticleFrontiers in immunology2021

Assessment of Expression of

Mohammad Taheri, Somayeh Sangseifid, Pariya Shahani, Mohammad Mahdi Eftekharian, Shahram Arsang-Jang, Soudeh Ghafouri-Fard

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Mohammad TaheriSkull Base Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Somayeh SangseifidDepartment of Immunology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Pariya ShahaniDepartment of Cellular Molecular Biology, Faculty of New Sciences, Medical Tehran Branch, Islamic Azad University, Tehran, Iran.
Mohammad Mahdi EftekharianNeurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
Shahram Arsang-JangCancer Gene Therapy Research Center, Zanjan University of Medical Science, Zanjan, Iran.
Soudeh Ghafouri-FardDepartment of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Hamedan University of Medical Sciences · IRShahid Beheshti University of Medical Sciences · IRIslamic Azad University Medical Branch of Tehran · IRZanjan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acquired immune-mediated polyneuropathies are classified to some subtypes among them are acute and chronic inflammatory demyelinating polyradiculoneuropathies (AIDP and CIDP). These two conditions share some common signs and underlying mechanisms. Based on the roles of

Indexed as

Disease SusceptibilityGene ExpressionAdultAgedAged, 80 and overCase-Control StudiesFemaleGene Expression RegulationHumansMaleMiddle AgedMultigene FamilyPolyneuropathiesPolyradiculoneuropathy, Chronic Inflammatory DemyelinatingROC CurveSuppressor of Cytokine Signaling ProteinsSuppressor of Cytokine Signaling Proteinsacquired immune-mediated polyneuropathiesAIDPCIDPGuillain-Barré syndromesuppressor of cytokine signaling

Identifiers

PMID34349769
PMCPMC8326791
OpenAlexW3188857186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.